Evidence map›Paper›PMID 22802411›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

SDF-1α degrades whereas glycoprotein 120 upregulates Bcl-2 interacting mediator of death extralong isoform: implications for the development of T cell memory.

Sergey A Trushin, Alberto A Carena, Gary D Bren, Stacey A Rizza, Xiangyang Dong, Roshini S Abraham, Andrew D Badley

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sergey A TrushinDivision of Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA.
Alberto A Carena
Gary D Bren
Stacey A Rizza
Xiangyang Dong
Roshini S Abraham
Andrew D Badley
Mayo Clinic in Arizona · USMayo Clinic · USMayo Clinic in Florida · US

Funding

Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.R01AI120698 · NIAID · MAYO CLINIC ROCHESTER · PI BADLEY, ANDREW D · 2015 to 2019
$2.5M
Procaspase 8 Activation by HIV ProteaseR01AI062261 · NIAID · MAYO CLINIC ROCHESTER · PI BADLEY, ANDREW D · 2004 to 2008
$1.5M
NIAID NIH HHS R01 AI062261NIAID NIH HHS R01 AI120698NIAID NIH HHS R01 AI62261
6 · The paper itself

Abstract

After a primary immune response, T cell memory occurs when a subset of Ag-specific T cells resists peripheral selection by acquiring resistance to TCR-induced death. Recent data have implicated Bcl-2 interacting mediator of death (Bim) as an essential mediator of the contraction phase of T cell immunity. In this article, we describe that stromal-derived factor-1α (SDF-1α) ligation of CXCR4 on activated T cells promotes two parallel processes that favor survival, phospho-inactivation of Foxo3A, as well as Bim extralong isoform (Bim(EL)) degradation, both in an Akt- and Erk-dependent manner. Activated primary CD4 T cells treated with SDF-1α therefore become resistant to the proapoptotic effects of TCR ligation or IL-2 deprivation and accumulate cells of a memory phenotype. Unlike SDF-1α, gp120 ligation of CXCR4 has the opposite effect because it causes p38-dependent Bim(EL) upregulation. However, when activated CD4 T cells are treated with both gp120 and SDF-1α, the SDF-1α-driven effects of Bim(EL) degradation and acquired resistance to TCR-induced death predominate. These results provide a novel causal link between SDF-1α-induced chemotaxis, degradation of Bim(EL), and the development of CD4 T cell memory.

Indexed as

ApoptosisApoptosis Regulatory ProteinsBcl-2-Like Protein 11CD4-Positive T-LymphocytesChemokine CXCL12Chemotaxis, LeukocyteFlow CytometryHumansImmunoblottingImmunologic MemoryImmunoprecipitationLymphocyte ActivationMembrane ProteinsProtein IsoformsProto-Oncogene ProteinsReceptors, CXCR4Apoptosis Regulatory ProteinsBCL2L11 protein, humanBcl-2-Like Protein 11Chemokine CXCL12CXCR4 protein, humanMembrane ProteinsProtein IsoformsProto-Oncogene ProteinsReceptors, CXCR4

Identifiers

PMID22802411
PMCPMC3530261
OpenAlexW2165869620

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.